(1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S340000

Reexamination Certificate

active

07378425

ABSTRACT:
The present invention provides an excellent sigma receptor binding agent and/or acetylcholinesterase inhibitor containing an (1-indanone)-(1,2,3,6-tetrahydropyridine) compound. More specifically, it provides an (1-indanone)-(1,2,3,6-tetrahydropyridine) compound represented by the following formula, a pharmacologically acceptable salt thereof or a hydrate thereof:In the formula (I), R1, R2, R3and R4are the same as or different from each other.

REFERENCES:
patent: 4895841 (1990-01-01), Sugimoto et al.
patent: 0296560 (1988-12-01), None
patent: 5-505172 (1993-08-01), None
patent: 6-329535 (1994-11-01), None
patent: 7-89949 (1995-04-01), None
patent: 9-508893 (1997-09-01), None
patent: 2733203 (1997-12-01), None
patent: 11-503140 (1999-03-01), None
patent: 11-34981 (1999-12-01), None
patent: 2000-319257 (2000-11-01), None
patent: 2000-319258 (2000-11-01), None
patent: 2001-139547 (2001-05-01), None
patent: WO-91/03243 (1991-03-01), None
patent: WO-95/15948 (1995-06-01), None
patent: WO-96/31208 (1996-10-01), None
Kato et al. “TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons”, Neuroscience Letters, vol. 260, pp. 5-8, 1999.
Walker et al. “Sigma receptors: biology and function”, Pharmacological Reviews, vol. 42, No. 4, pp. 355-402, 1990.
Folia Pharmacol. Jpn., vol. 114, pp. 3-11, 1999.
Gilligan et al. “Piperidinyltetralin o Ligands”, J. Med. Chem., Vo. 37, pp. 364-370, 1994.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

(1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with (1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2769839

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.